YS Biopharma Co., Ltd. (LSB): Growth-Adjusted P/E Ratio
LakeShore Biopharma Co. (LSB) combines cutting-edge adjuvant developments with a strict reliance on Chinese government procurement. The PEG ratio visualizes the resilience of this model, where 0.00 indicates the level of this metric. The business capitalization relies on the supply of influenza and rabies vaccines to Asian clinics.
LakeShore Biopharma Co. (LSB) - metric breakdowns and financial figures
To filter risks, LakeShore Biopharma Co. (LSB) must align its market value with earnings dynamics. The PEG ratio is calculated by dividing the P/E ratio by the business growth rate to determine whether the current price is fair. Analyzing the PEG multiplier chart allows for the identification of asset undervaluation. However, low values here may signal market skepticism due to corporate conflicts and price wars within the vaccine sector.
